On Monday, Johnson & Johnson Agreed To Pay $50M To Settle Claims Related To A Terminated Manufacturing Deal With Emergent BioSolutions Related To Johnson & Johnson's Covid-19 Vaccine - 8K
週一,強生同意支付5千萬美元,以解決與Emergent Biosolutions終止製造協議有關的索賠,涉及強生的covid-19生物-疫苗 - 8K